A new injection, benralizumab, outperforms traditional steroids in treating asthma and COPD attacks, reducing treatment ...
An injection of a drug already on the market, Benralizamab, promises to be the next revolution in the treatment of asthma ...
An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, ...
The antibody drug benralizumab is on the fast track to becoming the first new treatment for certain kinds of asthma and COPD ...
For the first time in half a century, scientists have hit on a new treatment for asthma attacks. Clinical trial results have ...
Benralizumab is already used in the most severe cases, but the latest research suggests it could be used routinely for around two million attacks in the UK each year ...
Researchers have found that an injection given during some asthma and Chronic Obstructive Pulmonary Disease (COPD) attacks reduces the need for further treatment by 30 per cent, which is more ...
The clinical trial, led by scientists from King’s College London and sponsored by the University of Oxford, with support from drug firm AstraZeneca UK, was conducted at Oxford University Hospitals NHS ...
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms.
A drug already used in the treatment of severe asthma could help treat exacerbations in asthma and COPD, a UK trial has found ...
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...